Richard C. Young & CO., LTD.
- SEC CIK
- 0001387304
- Latest filing
- Jul 28, 2026
NVS holding history
Novartis AG in every 13F filed by Richard C. Young & CO., LTD., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −131,600−100.0% | Sold out | Holders |
| Q1 2024 | 131,600 | $12.7M | 1.6% | −5,556−4.1% | Reduced | Holders |
| Q4 2023 | 137,156 | $13.8M | 1.9% | −2,967−2.1% | Reduced | Holders |
| Q3 2023 | 140,123 | $14.3M | 2.0% | −2,636−1.8% | Reduced | Holders |
| Q2 2023 | 142,759 | $14.4M | 2.0% | +322+0.2% | Added | Holders |
| Q1 2023 | 142,437 | $13.1M | 1.8% | +1,671+1.2% | Added | Holders |
| Q4 2022 | 140,766 | $12.8M | 1.7% | −392−0.3% | Reduced | Holders |
| Q3 2022 | 141,158 | $10.7M | 1.6% | −972−0.7% | Reduced | Holders |
| Q2 2022 | 142,130 | $12.0M | 1.6% | +1,724+1.2% | Added | Holders |
| Q1 2022 | 140,406 | $12.3M | 1.6% | +8,504+6.4% | Added | Holders |
| Q4 2021 | 131,902 | $11.5M | 1.5% | −5,016−3.7% | Reduced | Holders |
| Q3 2021 | 136,918 | $11.2M | 1.5% | −352−0.3% | Reduced | Holders |
| Q2 2021 | 137,270 | $12.5M | 1.6% | +3,154+2.4% | Added | Holders |
| Q1 2021 | 134,116 | $11.5M | 1.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.